February 10th, 2015

Staying Resolute in New Year’s Resolutions

By Chris Jordan, Director of Exercise Physiology, Human Performance Institute Division of Wellness and Prevention, Inc., a Johnson & Johnson company

We are just over a month into 2015, so how are your New Year’s Resolutions going? Many of us take a good look at ourselves at the end of each year and decide to embark on an overly optimistic exercise plan for the New Year with good intentions of losing weight and improving our health and fitness. Perhaps we even set goals such as getting in shape for the summer and looking good on the beach.

Chris-Jordan - Stay Motivated

We have all seen how busy the fitness centers are in January. It can be hard to get on our preferred cardio machine or get a spot in our favorite workout class. Like all New Year’s resolutions, the exercise resolution often starts well. We get up early every morning for a run or we make it to the gym every evening after work. We may even add a workout in during the weekend! And, we feel good. Not just physically (we know exercise can boost our energy levels), but also emotionally and mentally, partly because we did what we committed to do. We feel we accomplished something and we are on track with our plan for the New Year!

Read More

February 5th, 2015

Making Every Moment Matter

by Tara Glasgow, Vice President of Research & Development, Global Baby

Making Every Moment Matter

As a mom, I understand the need for other moms and dads to treasure the precious moments throughout the day we get to spend with our children. From bath time to bedtime, all of these moments turn into our very own special rituals and serve as a way to bond and develop a relationship with our little ones. What may come as a surprise to some is how all of these everyday interactions serve as the perfect opportunity to stimulate your baby’s senses, which we believe can have a positive impact on their development.

Working on JOHNSON’S®, I’ve had the chance to meet parents all over the world and look at the unique rituals and practices between them and their baby. What I found to be universal is the desire for families to raise happy, healthy babies.

As the first baby care brand to commit to advancing the science of baby’s skin, we feel, as scientists, an obligation to continue to take our research to the next level by looking at all the science— even beyond the science focused on cleansing— that help our babies thrive and grow. It’s why I am so excited about the new and existing research we are sharing that reveals the importance of multi-sensorial experiences that can lead to happy, healthy baby development.

Read More

January 29th, 2015

Working together to tackle vaccine preventable disease in children

by Johan Van Hoof, M.D., Global Therapeutic Area Head Infectious Diseases and Vaccines, Janssen Pharmaceutical Companies of Johnson & Johnson, and Managing Director, Crucell Holland B.V.


This week in Berlin, Gavi, The Vaccine Alliance, an organization which improves access to new and underused vaccines for children, brought together world leaders and stakeholders to welcome new commitments towards its mission to immunize children in developing countries. I am proud to say that Janssen, the pharmaceutical companies of Johnson & Johnson, were a part of this group which pledged a total of US$7.5 billion, which will enable countries to immunize an additional 300 million children.

I would personally like to congratulate the world community and Gavi on this renewed commitment and pledge which is expected to help save an estimated five to six million lives by 2020. In the 15 years since the international organization Gavi was founded, half a billion children have already received lifesaving vaccines through their work.

As a parent myself, I believe the dramatic decline in preventable child deaths during the past 25 years is one of humankind’s greatest achievements. Deadly and debilitating diseases are entirely preventable through immunization and by investing in vaccines, we can do far more than protect health; we can also protect people’s incomes and savings, and promote economic growth.

Read More

January 20th, 2015

WW Pharmaceuticals Chairman Joaquin Duato Shares His Leadership Perspectives in PwC’s 18th Annual Global CEO Survey

Joaquin Duato CEO Survey

Editor’s Note:  Joaquin Duato, Worldwide Chairman of our Janssen Pharmaceutical Companies, was asked to participate in the 18th Annual PricewaterhouseCoopers (PwC) LLC Global CEO Survey on behalf of Johnson & Johnson and our senior leadership team. Every year, PwC interviews top global leaders about the global economy and their perspectives on business challenges and opportunities.

This year’s survey focuses on themes such as strategies for business growth, the emergence of digital technology, and talent diversity and adaptability.  The survey results were shared earlier today in Davos, Switzerland on the eve of the Annual Meeting of the World Economic Forum.

We invite you to watch the PwC interview and hear Joaquin’s perspectives on topics including accelerating medical innovation, tech and big data development and addressing global threats such as the Ebola health crisis.

Learn more about Joaquin’s leadership role at Johnson & Johnson by visiting his senior management page bio.

Read More

January 14th, 2015

A new culture in science, a better outcome for public health

By Joanne Waldstreicher, MD, Chief Medical Officer, Johnson & Johnson

Innovation in the interest of public health happens faster when researchers in both the public and private sectors share information and work together. We’ve seen this happening to the greatest extent during the current Ebola epidemic. Imagine if this were the new culture and the new standard in science.  If done responsibly so that we could also maintain a healthy R&D ecosystem, sharing data from clinical studies can help advance the science that is the foundation of all medical care.

Our primary responsibility, as one of the most broadly based healthcare companies in the world, is to the doctors and nurses, patients and consumers, mothers, fathers and children who use our products. That means taking a patient and consumer-centered approach to advancing medical science through all of our products that touch people in different ways. It also means we have the opportunity to set the standard and be leaders and role models in advancing best practices that will ultimately advance science and medicine.

When we announced early last year that we would partner with the Yale School of Medicine Open Data Access Project (YODA) to serve as an independent reviewer for every request for clinical data from our pharmaceutical studies, we broke new ground in data transparency.

Read More

January 6th, 2015

Collaborating to Speed Development of an Ebola Vaccine

By Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Ebola continues to cause suffering among patients, families and health care workers in West Africa.  In response, the world’s scientific, pharmaceutical, regulatory, and public health communities have united in taking action to find new ways to collaborate and drive forward innovations to help prevent Ebola infection.  These collaborative efforts are happening at record pace, and they offer a window into what is possible in the face of a global epidemic.

Speed matters.  To date, almost 8,000 people have died from Ebola and more than 20,000 cases have been reported and the numbers continue to rise.

This sense of urgency has motivated our teams to work day and night in our labs and in close collaboration with partners such as the World Health Organization, U.S. Centers for Disease Control and Prevention, UK Medicines and Healthcare Products Regulatory Agency on finding a solution as fast as possible. Together we are working to accelerate the process of developing, producing and distributing a preventive Ebola vaccine regimen.

As a result of these collaborative efforts, today Johnson & Johnson announced the start of a Phase 1 first-in-human clinical trial of a preventive Ebola vaccine regimen in development at our Janssen Pharmaceutical Companies.

Read More

December 27th, 2014

The 10 Most-read Stories of 2014

Compiled by the Johnson & Johnson Social Media Team

From paying tribute to our military veterans to the continued fight against HIV and AIDS, Johnson & Johnson had a wealth of stories and news to share on a wide range of topics in 2014. Here’s a list of the top 10 JNJ Blog posts that readers clicked on the most. Visit us here in 2015 when we continue the conversation about J&J news and events.

10. Meet Our U.S. Military Veterans

In honor of Veterans Day this year, J&J recognized and thanked all those who served in the military, including our own employees. This post featured 27 employees who are veterans and work across our Pharmaceutical, Medical Devices & Diagnostics and Consumer segments.

9. Healthy Minds Program Explores Major Depressive Disorder

Across the globe, approximately 450 million people suffer from a mental or neurological disorder, yet nearly 60 percent who have a known disorder never consult a doctor to better understand their mental health.

Read More

December 22nd, 2014

Caring for our Heroes

by Susan Can, Senior Director of Corporate Equity and Strategic Partnerships, Johnson & Johnson

We have a very active employee Veterans Leadership Council at Johnson & Johnson, and in partnership with them, we’ve had an exciting year supporting our servicemen and women, and their families in 2014. Here’s a snapshot of the work we’ve done this year:

In February, we were pleased to announce our partnership with American Corporate Partners (ACP), a unique non-profit organization dedicated to assisting U.S. military veterans in their transition from the military to the civilian workforce. Johnson & Johnson Chairman and CEO Alex Gorsky was also featured in a public service announcement encouraging people with business skills to share their valuable experience and guidance at ACP-AdvisorNet because “their service deserves our service.”

In April, Johnson & Johnson signed on to be the Official Healthcare Partner of the USO. Over the course of this three-year partnership, Johnson & Johnson will support and sponsor USO programs that offer direct aid, comfort and support to transitioning troops and their families.

USO Heroes

That same month, we were honored to participate in the official opening of the USO Warrior and Family Center at Naval Support Activity Bethesda, home of Walter Reed National Military Medical.

Read More

December 19th, 2014

When It’s More Than Joint Pain

by Jack L. Groppel, Ph.D., FACSM, Co-Founder, Johnson & Johnson Human Performance Institute, Inc.

When most people think about the effects of osteoarthritis (OA) on their life, they think about how it impacts them physically – how they may not be able to walk long distances anymore, or sit on the ground to play with their grandchildren. But what many don’t consider is the effect OA also has on their emotional, mental and spiritual energy or the quality, focus and force of one’s energy.

I fought joint pain every day for almost three decades, and it took up much of my best energy and left me with little for my family and work. I used to run or play tennis every day. Due to my OA, my personal trainers consistently told me I should not be running, but cycling and swimming instead. But, you see (and here comes the flawed thinking), I was busy. It took too long to change my exercise routine, and I got bored. I loved the action I got from a tennis workout, or from a four-mile run.

Over time, the pain in my knees combined with my desire to push myself physically forced me to give up many of the things I loved.

Read More

December 18th, 2014

J&J Products Earn Earthwards® Recognition a Year Early

by Al Iannuzzi, Ph.D., Senior Director, Worldwide Environment, Health, Safety, & Sustainability, Johnson & Johnson

EarthwardsSustainability is increasingly driving global hospital purchasing decisions, but a perceived lack of available products with sustainable features remains a barrier to those decisions. According to a 2014 global Harris Poll survey of health care professionals, more than half (54 percent) say their hospitals currently incorporate sustainability into purchasing decisions, and 80 percent expect that to be the case by 2016. In the same study, commissioned by Johnson & Johnson, 67 percent of respondents cited a lack of available products with sustainable features as one of the greatest perceived barriers to those purchasing decisions.

Consumers are echoing this demand, with 93 percent of respondents to a 2013 global CSR study saying they would like to see more products, services, or retailers support worthy social and environmental issues. Another 91 percent would switch brands to a product that addressed these issues.


At Johnson & Johnson, innovation is everyone’s responsibility. It is derived from the insight and spirit of our employees, and it is fueled by our ability to anticipate and understand our patients’ and customers’ needs. One quarter of our global revenue comes from products introduced within the past five years, which means it is also a core component to our business success.

Read More